Lumoxiti

moxetumomab pasudotox-tdfk · Gilead Sciences

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Lumoxiti, covering 2021-08-11 to 2025-07-18. Get the full timeline:

Most recent: Clinical Trial Update: US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)